Press Releases
July 2009
PharmaForce Inc. receives FDA approval
Friday 31 Jul, 2009
Cell Therapeutics initiates process to obtain marketing approval
Wednesday 29 Jul, 2009
Roxane Laboratories launches Risperidone Oral Solution 1mg/ml
Wednesday 29 Jul, 2009
FDA issues complete response letter for INTUNIV(TM) (guanfacine) extended
Tuesday 28 Jul, 2009
MULTAQ(R) (dronedarone) for atrial fibrillation or atrial flutter now available in the United States
Tuesday 28 Jul, 2009
Bristol-Myers Squibb begins tender offer to acquire Medarex, Inc.
Tuesday 28 Jul, 2009
Movetis Receives Positive Opinion by the CHMP on European Marketing
Monday 27 Jul, 2009
Malvern’s Morphologi G3 used in allergy research
Tuesday 21 Jul, 2009
Dow AgroSciences, NemGenix establish new collaboration in plant
Thursday 16 Jul, 2009
FDA approves NovoLog(R) labeling update
Wednesday 15 Jul, 2009
Johnson & Johnson Completes Acquisition of Cougar Biotechnology
Tuesday 14 Jul, 2009
Improving Transfusion Safety: Fenwal, Verax Biomedical Sign Agreement for Rapid, Point-of-Care Bacteria Test
Tuesday 14 Jul, 2009
Cornerstone Therapeutics Signs Definitive Asset Purchase Agreement to Acquire Commercial Rights to the Antibiotic Factive(R)
Tuesday 14 Jul, 2009
Sunesis Pharmaceuticals Receives Milestone Payment From Biogen Idec
Monday 13 Jul, 2009
Celtic Pharma Holdings Announces Investment in Novacta Biosystems Limited
Monday 6 Jul, 2009
Seambiotic USA and NASA Glenn Research Center Signed Agreement for Large Scale Microalgae Process Optimization
Thursday 2 Jul, 2009
Emission control Sturtevant and Malvern Instruments combine expertise for optimal sorbent milling
Thursday 2 Jul, 2009
© 2010 Ochre Media. All rights reserved.